Poster Session 2
Mathilde Lepelletier, N/A (she/her/hers)
Resident
INSERM UMR 1153, Obstetrical , Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics, FHU PREMA, Université de Paris
Paris, Ile-de-France, France
Camille Le Ray, MD, PhD (she/her/hers)
Professor
INSERM 1153, APHP, Port Royal maternity unit, Université de Paris
Paris, Ile-de-France, France
Aude Girault, MD, PhD (she/her/hers)
FHU PREMA, Paris, France. FHU PREMA, Paris, France; Université Paris Cité, Inserm, Centre for Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), Paris, France.
Paris, Ile-de-France, France
A total of 14,168 women were included, 7,529 in 2016 and 6,639 in 2021. The incidence of severe PPH increased from 1.2% in 2016 to 2.0% in 2021, p< 0.01. The use of oxytocin during labor decreased from 45.0% in 2016 to 30.2% in 2021, p< 0.01. Labor duration were significantly longer in 2021, regardless of parity (p < 0.01) After adjusting for maternal, obstetrical and maternity unit characteristics, giving birth in 2021 (versus 2016) remained associated with an increased risk of severe PPH (OR 1.7 [1.3-2.2]). While oxytocin use did not appear as a mediating factor, prolonged labor mediated only 9% of the observed association between the year of delivery and the risk of severe PPH.
While the French Labor management Guidelines could partially explain the increase in severe PPH rates observed between 2016 and 2021, the decrease in the use of oxytocin does not appear to be associated with this increase.